Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.18330DOI Listing

Publication Analysis

Top Keywords

current advances
4
advances 2024
4
2024 critical
4
critical review
4
review selected
4
selected topics
4
topics association
4
association advancement
4
advancement blood
4
blood biotherapies
4

Similar Publications

Discovery of -(thiazol-2-yl) Furanamide Derivatives as Potent Orally Efficacious AR Antagonists with Low BBB Permeability.

J Med Chem

September 2025

State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Resistance-conferring mutations in the androgen receptor (AR) ligand-binding pocket (LBP) compromise the effectiveness of clinically approved orthosteric AR antagonists. Targeting the dimerization interface pocket (DIP) of AR presents a promising therapeutic approach. In this study, we report the design and optimization of -(thiazol-2-yl) furanamide derivatives as novel AR DIP antagonists, among which was the most promising candidate.

View Article and Find Full Text PDF

Incretin Signaling Neighborhoods and Adverse Drug Reactions.

Annu Rev Pharmacol Toxicol

September 2025

1Department of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden; email:

In light of the success of blockbuster drugs for type 2 diabetes and obesity based on the GLP-1 hormone, drugmakers have concentrated their efforts on developing new and improved variations that address the route of administration, dosing, pathway selectivity, or polypharmacology. While some of these modifications have demonstrated improved efficacy in clinical studies and offered exciting opportunities for treating other diseases, drug-induced shifts to the conformational landscape of target receptors may have consequences for side effects. Our review summarizes advances in the understanding of the biochemistry, pharmacogenomics, and molecular pharmacology of incretins and their cognate receptors.

View Article and Find Full Text PDF

Skin-adaptive focused flexible micromachined ultrasound transducers for wearable cardiovascular health monitoring.

Sci Adv

September 2025

State Key Laboratory for Manufacturing System Engineering, State Industry-Education Integration Center for Medical Innovations, International Joint Laboratory for Micro/Nano Manufacturing and Measurement Technologies, Shaanxi Innovation Center for Special Sensing and Testing Technology in Extreme En

Continuous monitoring of cardiovascular vital signs can reduce the incidence and mortality of cardiovascular diseases, yet cannot be implemented by current technologies because of device bulkiness and rigidity. Here, we report self-adhesive and skin-conformal ultrasonic transducer arrays that enable wearable monitoring of multiple hemodynamic parameters without interfering with daily activities. A skin-adaptive focused ultrasound method with rational array design is proposed to implement measurement under wide ranges of skin curvatures and depths with improved sensing performances.

View Article and Find Full Text PDF

Automated vehicles (AVs) have the potential to enhance transportation for all, but current research suggests that women remain less engaged and more hesitant toward their adoption. This scoping review systematically analyses 34 peer-reviewed studies published between 2016 and 2025 to assess how women's experiences, needs, and concerns are represented in AV research. Using thematic analysis, we identify key facilitators and barriers to AV adoption and map them onto a Socio-Ecological Model spanning five levels: individual, interpersonal, institutional, community, and policy.

View Article and Find Full Text PDF

Amino Acid Metabolism in Cancer Cachexia and Chemotherapy Myotoxicity.

Am J Physiol Cell Physiol

September 2025

Division of Medical Sciences, NOSM University, Ontario, Canada.

Cancer induced skeletal muscle wasting (cachexia) is responsible for over 20% of cancer related deaths, yet much about the pathophysiology of the condition remains unknown. Importantly, cancer cachexia does not seem wholly responsive to traditional anabolic stimuli such as nutritional interventions. It is possible that tumours directly or indirectly target skeletal muscle for their dynamic and abundant pool of amino acids that can be reliably used by tumours to supplement energy production and biomass synthesis.

View Article and Find Full Text PDF